---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-23-037141"
form_type: "8-K"
ticker: "LENZ"
cik: "0001815776"
company_name: "LENZ Therapeutics, Inc."
filed_at: "2023-08-02T23:59:59+00:00"
generated_at: "2026-06-12T14:35:50.858261+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "high"
source: SEC EDGAR
---

# Graphite Bio appoints Kimberlee Drapkin as independent director

## Summary
- Board expanded from 10 to 11; Drapkin appointed effective July 28, 2023.
- Drapkin has 25+ years biotech/pharma experience; formerly CFO at Jounce Therapeutics.
- She will receive cash and equity under Director Compensation Policy, prorated from appointment.
- No arrangements or family relationships with other directors or executive officers.
- She serves on boards of Acumen Pharmaceuticals, Imugene, and Kineta.

## SEC filing metadata
- accession: 0000950170-23-037141
- form_type: 8-K
- ticker: LENZ
- cik: 0001815776
- company_name: LENZ Therapeutics, Inc.
- filed_at: 2023-08-02T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1815776/000095017023037141/0000950170-23-037141-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1815776/000095017023037141/grph-20230728.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-23-037141
- JSON: https://secwatch.observer/filing/0000950170-23-037141.json
- Plain text: https://secwatch.observer/filing/0000950170-23-037141.txt

## Key facts
- Executive change
  Kimberlee C. Drapkin was appointed as director at LENZ Therapeutics, Inc..
  - Action: appointed
  - Role: director
  source text: On July 28, 2023, the Board of Directors (the “Board”) of Graphite Bio, Inc. (the “Company”) increased the size of the Board from ten to eleven members and appointed Kimberlee C. Drapkin as a director of the Company, effective immediately
  evidence_url: https://www.sec.gov/Archives/edgar/data/1815776/000095017023037141/0000950170-23-037141-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.